Learn About Tricuspid Atresia

What is the definition of Tricuspid Atresia?

Tricuspid atresia is a type of heart disease that is present at birth (congenital heart disease), in which the tricuspid heart valve is missing or abnormally developed. The defect blocks blood flow from the right atrium to the right ventricle. Other heart or vessel defects are usually present at the same time.

What are the alternative names for Tricuspid Atresia?

Tri atresia; Valve disorder - tricuspid atresia; Congenital heart - tricuspid atresia; Cyanotic heart disease - tricuspid atresia

What are the causes of Tricuspid Atresia?

Tricuspid atresia is an uncommon form of congenital heart disease. It affects about 5 in every 100,000 live births. One in five people with this condition will also have other heart problems.

Normally, blood flows from the body into the right atrium, then through the tricuspid valve to the right ventricle and on to the lungs. If the tricuspid valve does not open, the blood cannot flow from the right atrium to the right ventricle. Because of the problem with the tricuspid valve, blood ultimately cannot enter the lungs. This is where it must go to pick up oxygen (becomes oxygenated).

Instead, the blood passes through a hole between the right and left atrium. In the left atrium, it mixes with oxygen-rich blood returning from the lungs. This mix of oxygen-rich and oxygen-poor blood is then pumped out into the body from the left ventricle. This causes the oxygen level in the blood to be lower than normal.

In people with tricuspid atresia, the lungs receive blood either through a hole between the right and left atria (described above), or through maintenance of a fetal vessel called the ductus arteriosus. The ductus arteriosus connects the pulmonary artery (artery to the lungs) to the aorta (main artery to the body). It is present when a baby is born, but normally closes by itself shortly after birth.

What are the symptoms of Tricuspid Atresia?

Symptoms include:

  • Bluish color to the skin (cyanosis) due to low oxygen level in the blood
  • Fast breathing
  • Fatigue
  • Poor growth
  • Shortness of breath
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Tricuspid Atresia?

Once the diagnosis is made, the baby will often be admitted to the neonatal intensive care unit (NICU). A medicine called prostaglandin E1 may be used to keep the ductus arteriosis open (patent) so that blood can circulate to the lungs.

Generally, patients with this condition require surgery. If the heart is unable to pump enough blood out to the lungs and rest of the body, the first surgery most often takes place within the first few days of life. In this procedure, an artificial shunt is inserted to keep blood flowing to the lungs. In some cases, this first surgery is not needed.

Afterward, the baby goes home in most cases. The child will need to take one or more daily medicines and be closely followed by a pediatric cardiologist. This doctor will decide when the second stage of surgery should be done.

The next stage of surgery is called the Glenn shunt or hemi-Fontan procedure. This procedure connects half of the veins carrying oxygen-poor blood from the upper half of the body directly to the pulmonary artery. The surgery is most often done when the child is between 4 to 6 months old.

During stage I and II, the child may still look blue (cyanotic).

Stage III, the final step, is called the Fontan procedure. The rest of the veins carrying oxygen-poor blood from the body are connected directly to the pulmonary artery leading to the lungs. The left ventricle now only has to pump to the body, not the lungs. This surgery is usually performed when the child is 18 months to 3 years old. After this final step, the baby's skin is no longer blue.

Who are the top Tricuspid Atresia Local Doctors?
Elite in Tricuspid Atresia
Elite in Tricuspid Atresia
New Delhi, DL, IN 

Sachin Talwar practices in New Delhi, India. Mr. Talwar and is rated as an Elite expert by MediFind in the treatment of Tricuspid Atresia. His top areas of expertise are Tricuspid Atresia, Ventricular Septal Defects, Transposition of the Great Arteries, Thrombectomy, and Stent Placement.

Joyce W. Wald
Advanced in Tricuspid Atresia
Cardiology | Advanced Heart Failure and Transplant Cardiology
Advanced in Tricuspid Atresia
Cardiology | Advanced Heart Failure and Transplant Cardiology

Penn Heart And Vascular Center At Perelman Center For Advanced Medicine

3400 Civic Center Blvd, East Pavilion, 2nd Floor, 
Philadelphia, PA 
Languages Spoken:
English
Offers Telehealth

Joyce Wald is a Cardiologist and an Advanced Heart Failure and Transplant Cardiologist in Philadelphia, PA. Dr. Wald and is rated as an Advanced provider by MediFind in the treatment of Tricuspid Atresia. Her top areas of expertise are Heart Failure, Cardiogenic Shock, Cardiomyopathy, Heart Transplant, and Gastrostomy.

 
 
 
 
Learn about our expert tiers
Learn More
Advanced in Tricuspid Atresia
Cardiology | Pediatric Cardiology
Advanced in Tricuspid Atresia
Cardiology | Pediatric Cardiology

Prisma Health University Medical Group

175 Patewood Dr, 
Greenville, SC 
Languages Spoken:
English, Castilian, Spanish
Accepting New Patients

Manisha Shanbhag is a Cardiologist and a Pediatric Cardiologist in Greenville, South Carolina. Dr. Shanbhag and is rated as an Advanced provider by MediFind in the treatment of Tricuspid Atresia. Her top areas of expertise are Eisenmenger Syndrome, Ventricular Septal Defects, Atrioventricular Septal Defect, and Endocardial Cushion Defect. Dr. Shanbhag is currently accepting new patients.

What is the outlook (prognosis) for Tricuspid Atresia?

In most cases, surgery will improve the condition.

What are the possible complications of Tricuspid Atresia?

Complications may include:

  • Irregular, fast heart rhythms (arrhythmias)
  • Chronic diarrhea (from a disease called protein-losing enteropathy)
  • Heart failure
  • Fluid in the abdomen (ascites) and in the lungs (pleural effusion)
  • Blockage of the artificial shunt
  • Strokes and other nervous system complications
  • Sudden death
When should I contact a medical professional for Tricuspid Atresia?

Contact your health care provider right away if your infant has:

  • New changes in breathing patterns
  • Problems eating
  • Skin that is turning blue
How do I prevent Tricuspid Atresia?

There is no known way to prevent tricuspid atresia.

Women who plan to become pregnant should be immunized against rubella if they are not already immune. Rubella infection in a pregnant woman can cause congenital heart disease.

Women who are pregnant should get good prenatal care:

  • Avoid alcohol and illegal drugs during pregnancy.
  • Tell your provider that you are pregnant before taking any new medicines.
  • Have a blood test early in your pregnancy to see if you are immune to rubella. If you are not immune, avoid any possible exposure to rubella and get vaccinated right after delivery.
  • Pregnant women who have diabetes should try to get good control over their blood sugar level.

Some inherited factors may play a role in congenital heart disease. Many family members may be affected. If you are planning to get pregnant, talk to your provider about screening for genetic diseases.

What are the latest Tricuspid Atresia Clinical Trials?
Do Cerebral and Renal Saturations Measured With Near-infrared Spectroscopy Correlate With Echocardiographic Markers of Perfusion and Cardiac Performance in Congenital Heart Disease?

Summary: Neonatal patients with congenital heart defects (CHD) have changing physiology in the context of transitional period. Patients with CHD are at risk of low perfusion status or abnormal pulmonary blood flow. Near infrared spectroscopy has been used in neonatal intensive care units (NICU) to measure end-organ perfusion. The investigator plan on monitoring newborns with CHD admitted to the NICU with N...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Prospective, Open-labeled, Single-arm Clinical Trial to Evaluate the Safety and Efficacy of the Second-generation Tissue Engineered Vascular Graft as Vascular Conduits for Extracardiac Total Cavopulmonary Connection.

Summary: A single arm clinical trial evaluating the safety and efficacy of the second generation TEVG as vascular conduits for extracardiac total cavopulmonary connection.

Who are the sources who wrote this article ?

Published Date: October 23, 2023
Published By: Michael A. Chen, MD, PhD, Associate Professor of Medicine, Division of Cardiology, Harborview Medical Center, University of Washington Medical School, Seattle, WA. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Valente AM, Dorfman AL, Babu-Narayan SV, Kreiger EV. Congenital heart disease in the adolescent and adult. In: Libby P, Bonow RO, Mann DL, Tomaselli GF, Bhatt DL, Solomon SD eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 12th ed. Philadelphia, PA: Elsevier; 2022:chap 82.

Well A, Fraser CD. Congenital heart disease. In: Townsend CM Jr, Beauchamp RD, Evers BM, Mattox KL, eds. Sabiston Textbook of Surgery. 21st ed. St Louis, MO: Elsevier; 2022:chap 59.